Assembly Biosciences Inc (ASMB) — Cash Flow-to-Debt Ratio
Assembly Biosciences Inc (ASMB) has a Cash Flow-to-Debt Ratio of -0.26x as of September 2025, meaning its operating cash flow of $-15.13 Million could theoretically repay 0% of its total liabilities ($57.30 Million) in one year. See ASMB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Assembly Biosciences Inc Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Assembly Biosciences Inc across 17 annual periods. Also explore Assembly Biosciences Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Assembly Biosciences Inc (2008–2024)
Year-by-year debt coverage analysis for Assembly Biosciences Inc. For market capitalisation and broader financial context, see ASMB stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.60x | $-51.12 Million | $85.81 Million | ▼ -350.7% |
| 2023 | 0.24x | $22.74 Million | $95.73 Million | ▲ +105.4% |
| 2022 | -4.42x | $-84.46 Million | $19.13 Million | ▼ -4.6% |
| 2021 | -4.22x | $-93.40 Million | $22.13 Million | ▼ -186.1% |
| 2020 | -1.48x | $-62.96 Million | $42.68 Million | ▼ -31.0% |
| 2019 | -1.13x | $-84.07 Million | $74.67 Million | ▲ +0.5% |
| 2018 | -1.13x | $-64.96 Million | $57.39 Million | ▼ -3518.7% |
| 2017 | 0.03x | $1.86 Million | $56.18 Million | ▲ +101.7% |
| 2016 | -1.91x | $-34.88 Million | $18.24 Million | ▼ -53.4% |
| 2015 | -1.25x | $-18.70 Million | $15.00 Million | ▼ -5.3% |
| 2014 | -1.18x | $-14.97 Million | $12.65 Million | ▲ +82.5% |
| 2013 | -6.75x | $-17.80 Million | $2.64 Million | ▲ +13.4% |
| 2012 | -7.79x | $-21.38 Million | $2.75 Million | ▲ +21.9% |
| 2011 | -9.98x | $-25.07 Million | $2.51 Million | ▼ -472.1% |
| 2010 | -1.74x | $-5.21 Million | $2.99 Million | ▼ -577.1% |
| 2009 | -0.26x | $-3.48 Million | $13.53 Million | ▲ +35.9% |
| 2008 | -0.40x | $-4.15 Million | $10.33 Million | — |